Federal Select Agent Program Compliance
WebinarA public webcast of the Multi-Agency Informational Meeting Concerning Compliance with the Federal Select Agent Program will be held February 8, 2017. The HHS/CDC's Division of Select Agents and Toxins
A public webcast of the Multi-Agency Informational Meeting Concerning Compliance with the Federal Select Agent Program will be held February 8, 2017. The HHS/CDC's Division of Select Agents and Toxins
The Food and Drug Administration (FDA) will host a public workshop entitled “Identification and Characterization of the Infectious Disease Risks of Human Cells, Tissues, and Cellular and Tissue-based Products” on
The 2017 Mass Gathering Medicine Summit will be held February 10-11, 2017 in Las Vegas, Nevada. The annual Mass-Gathering Medicine Summit provides the only annual conference and symposium for mass-gathering
The Bacteriophage 2017 conference is scheduled to take place February 12-13, 2017 in Kuala Lumpur, Malaysia. The ICB 2017: 19th International Conference on Bacteriophages aims to bring together leading academic scientists, researchers
Now in its third year, CBRN International, formerly known as CBRN First Response, will take place February 16, 2017 in Coventry, UK. Supported by the UK National CBRN Centre, this
The George Mason University (GMU) Schar School of Policy and Government will host a Master’s Open House on February 16, 2017 from 6:30 pm - 8:30 pm in Arlington, Virginia. The event will
The Molecular Med TRI-CON 2017 conference event will be held February 19-24, 2017 in San Francisco, California. This annual event focuses on molecular medicine research and methodologies, including discovery, genomics,
The Fort Detrick Alliance will host a Networking Breakfast on February 22, 2017 in Frederick, Maryland. The event’s featured guest is Dr. Pat Fitch, Director, National Biodefense Analysis and Countermeasures Center
SMi Group's 2017 RNA Therapeutics conference will be held February 22-23, 2017 in London, United Kingdom. This conference intends to review clinical trial updates in RNA- based therapeutics and discuss the